/CNW/ - André Picard, health reporter and columnist for The Globe and Mail, and Dr. Sanjay Gupta, chief medical correspondent for CNN, will be in back-to-back.
In-Hospital Resuscitation: Focus on Effective Chest Pumps, Shocks medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Acurate neo2 TAVR Valve Demonstrate Reduced Paravalvular Leak and Low Permanent Pacemaker Rates
Late-breaking registry data at EuroPCR shows better outcomes than first-generation Acurate neo device.
The Acurate neo2 TAVR valve design enhancements include a 60% larger outer sealing skirt to conform to challenging anatomies. This has minimized paravalvular leaks and imporved clinical outcomes compared to the previous-generation Acurate neo Aortic Valve System.
May 26, 2021 Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress for the updated Boston Scientific Acurate neo2 transcatheter aortic valve replacement (TAVR) system demonstrated positive procedural performance. This including low rates of paravalvular leakage (PVL) and permanent pacemaker implementation (PPI), areas where the first generation Acurate neo heart valve did not perform as well.
Posted5/19/2021 6:00 AM
There are few greater sacrifices than serving your country. It is a sacrifice that means spending months, or even years, away from family, which can take an emotional and even financial toll. That s where SALUTE, INC. comes in.
SALUTE, INC. was founded in 2003 by Will and Mary Beth Beiersdorf. Will, a Naval reservist, was deployed to Guantanamo Bay, Cuba, shortly after 9/11. He was there for 13 months, leaving Mary Beth and his kids behind do deal with the many unknowns that come with service. They were able to get by thanks to family and friends.
They wanted to extend that same helping hand by creating SALUTE, INC., a 501(c)(3) nonprofit organization that provides financial support through fundraisers.
In a concrete hangar in Aguadilla, Puerto Rico,
Katrina Mayes is working with precision and purpose. Wisps of smoke surround her, wafting off the dry ice she is using to jerry-rig a cardboard vaccine carrier. Her task: to create a vapor phase vent to moderate the temperature of the cooling container from around minus 80 degrees Celsius (for storing Pfizer’s COVID-19 vials) to minus 15 degrees Celsius (to accommodate supplies of the Moderna vaccine).
At 29, the biochemist and virologist has spent much of her professional life indoors, where the U.S. government has entrusted her to handle some of the world’s most lethal pathogens including Ebola, Lassa fever, and Nipah viruses at top-secret Biosafety Level Four facilities. “I shower six times a day,” she tells me. “I’m the cleanest person you’ll ever meet.” Her winning smile and gallows humor mask the gravity of her work, which has involved diffusing poison-laced letters that have been mailed to federal buildings.